Peijia Medical (PEIJIA-B) saw its stock price plummet by 5.21% in early trading on Wednesday after the company reported its full-year financial results. The medical device manufacturer's shares tumbled as investors reacted to the substantial net loss reported for the fiscal year.

According to the financial report, Peijia Medical posted a net loss of RMB 228.5 million for the year. This significant loss appears to be the primary driver behind the stock's sharp decline. Despite the negative bottom line, the company reported annual revenue of RMB 615.5 million and a gross profit of RMB 433.6 million, maintaining a robust gross margin of 70.5%.

The company also disclosed its capital expenditure for the year, which stood at RMB 280.1 million. This substantial investment suggests that Peijia Medical continues to focus on growth and expansion, despite the current financial challenges. However, investors seem to be more concerned about the company's profitability in the short term, as reflected in the stock's negative performance following the earnings release.